Efficient Generation of Functional Dopaminergic Neurons from Human Induced Pluripotent Stem Cells Under Defined Conditions

Abstract

Human induced pluripotent stem cells (iPSCs) reprogrammed from somatic cells represent a promising unlimited cell source for generating patient-specific cells for biomedical research and personalized medicine. As a first step, critical to clinical applications, we attempted to develop defined culture conditions to expand and differentiate human iPSCs into functional progeny such as dopaminergic neurons for treating or modeling Parkinson's disease (PD). We used a completely defined (xeno-free) system that we previously developed for efficient generation of authentic dopaminergic neurons from human embryonic stem cells (hESCs), and applied it to iPSCs. First, we adapted two human iPSC lines derived from different somatic cell types for the defined expansion medium and showed that the iPSCs grew similarly as hESCs in the same medium regarding pluripotency and genomic stability. Second, by using these two independent adapted iPSC lines, we showed that the process of differentiation into committed neural stem cells (NSCs) and subsequently into dopaminergic neurons was also similar to hESCs. Importantly, iPSC-derived dopaminergic neurons were functional as they survived and improved behavioral deficits in 6-hydroxydopamine-leasioned rats after transplantation. In addition, iPSC-derived NSCs and neurons could be efficiently transduced by a baculoviral vector delivering episomal DNA for future gene function study and disease modeling using iPSCs. We also performed genome-wide microarray comparisons between iPSCs and hESCs, and we derived NSC and dopaminergic neurons. Our data revealed overall similarity and visible differences at a molecular level. Efficient generation of functional dopaminergic neurons under defined conditions will facilitate research and applications using PD patient-specific iPSCs.

Shown for reading. Its publisher allows quoting it, not republishing it.

References 26

1. 1.

   Yan Y, Yang D, Zarnowska ED, et al. Directed differentiation of dopaminergic neuronal subtypes from human embryonic stem cells. Stem Cells. 2005;23:781-790.

   Not in our library10.1634/stemcells.2004-0365

2. 2.

   Zeng X, Cai J, Chen J, et al. Dopaminergic differentiation of human embryonic stem cells. Stem Cells. 2004;22:925-940.

   Not in our library10.1634/stemcells.22-6-925

3. 3.

   Perrier AL, Tabar V, Barberi T, et al. Derivation of midbrain dopamine neurons from human embryonic stem cells. Proc Natl Acad Sci USA. 2004;101:12543-12548.

   Not in our library10.1073/pnas.0404700101

4. 4.

   Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science. 1998;282:1145-1147.

   Not in our library10.1126/science.282.5391.1145

5. 5.
   Xeno-free defined conditions for culture of human embryonic stem cells, neural stem cells and dopaminergic neurons derived from them. · 2009

   Not checked
6. 6.

   Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131:861-872.

   Not in our library10.1016/j.cell.2007.11.019

7. 7.

   Chin MH, Mason MJ, Xie W, et al. Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell. 2009;5:111-123.

   Not in our library10.1016/j.stem.2009.06.008

8. 8.

   Soldner F, Hockemeyer D, Beard C, et al. Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell. 2009;136:964-977.

   Not in our library10.1016/j.cell.2009.02.013

9. 9.

   Chambers SM, Fasano CA, Papapetrou EP, et al. Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat Biotechnol. 2009;27:275-280.

   Not in our library10.1038/nbt.1529

10. 10.

    Wernig M, Zhao JP, Pruszak J, et al. Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc Natl Acad Sci USA. 2008;105:5856-5861.

    Not in our library10.1073/pnas.0801677105

11. 11.

    Ye Z, Zhan H, Mali P, et al. Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders. Blood. 2009;114:5473-5480.

    Not in our library10.1182/blood-2009-04-217406

12. 12.

    Zeng X, Chen J, Sanchez JF, et al. Stable expression of hrGFP by mouse embryonic stem cells: Promoter activity in the undifferentiated state and during dopaminergic neural differentiation. Stem Cells. 2003;21:647-653.

    Not in our library10.1634/stemcells.21-6-647

13. 13.

    Saeed AI, Bhagabati NK, Braisted JC, et al. TM4 microarray software suite. Methods Enzymol. 2006;411:134-193.

    Not in our library10.1016/s0076-6879(06)11009-5

14. 14.

    Peng J, Wu Z, Wu Y, et al. Inhibition of caspases protects cerebellar granule cells of the weaver mouse from apoptosis and improves behavioral phenotype. J Biol Chem. 2002;277:44285-44291.

    Not in our library10.1074/jbc.m207407200

15. 15.

    Peng J, Peng L, Stevenson FF, et al. Iron and paraquat as synergistic environmental risk factors in sporadic Parkinson's disease accelerate age-related neurodegeneration. J Neurosci. 2007;27:6914-6922.

    Not in our library10.1523/jneurosci.1569-07.2007

16. 16.

    Mali P, Chou BK, Yen J, et al. Butyrate greatly enhances derivation of human induced pluripotent stem cells by promoting epigenetic remodeling and the expression of pluripotency-associated genes. Stem Cells. 2010;28:713-720.

    Not in our library10.1002/stem.402

17. 17.

    Mali P, Ye Z, Chou BK, et al. An improved method for generating and identifying human induced pluripotent stem cells. Methods Mol Biol. 2010;636:191-205.

    Not in our library10.1007/978-1-60761-691-7_12

18. 18.

    Liu Y, Shin S, Zeng X, et al. Genome wide profiling of human embryonic stem cells (hESCs), their derivatives and embryonal carcinoma cells to develop base profiles of U.S. Federal government approved hESC lines. BMC Dev Biol. 2006;6:20.

    Not in our library10.1186/1471-213x-6-20

19. 19.

    Nichols J, Smith A. Naive and primed pluripotent states. Cell Stem Cell. 2009;4:487-492.

    Not in our library10.1016/j.stem.2009.05.015

20. 20.

    Yu J, Hu K, Smuga-Otto K, et al. Human induced pluripotent stem cells free of vector and transgene sequences. Science. 2009;324:797-801.

    Not in our library10.1126/science.1172482

21. 21.

    Shi Y, Do JT, Desponts C, et al. A combined chemical and genetic approach for the generation of induced pluripotent stem cells. Cell Stem Cell. 2008;2:525-528.

    Not in our library10.1016/j.stem.2008.05.011

22. 22.

    Hockemeyer D, Soldner F, Beard C, et al. Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases. Nat Biotechnol. 2009;27:851-857.

    Not in our library10.1038/nbt.1562

23. 23.

    Zou J, Maeder ML, Mali P, et al. Gene targeting of a disease-related gene in human induced pluripotent stem and embryonic stem cells. Cell Stem Cell. 2009;5:97-110.

    Not in our library10.1016/j.stem.2009.05.023

24. 24.

    Ross OA, Toft M, Whittle AJ, et al. Lrrk2 and Lewy body disease. Ann Neurol. 2006;59:388-393.

    Not in our library10.1002/ana.20731

25. 25.

    Mata IF, Wedemeyer WJ, Farrer MJ, et al. LRRK2 in Parkinson's disease: Protein domains and functional insights. Trends Neurosci. 2006;29:286-293.

    Not in our library10.1016/j.tins.2006.03.006

26. 26.

    Karra D, Dahm R. Transfection techniques for neuronal cells. J Neurosci. 2010;30:6171-6177.

    Not in our library10.1523/jneurosci.0183-10.2010

Cited by papers we hold 5

• Genetic predispositions of Parkinson’s disease revealed in patient-derived brain cells · 2020
  No notice
• High-throughput compound evaluation on 3D networks of neurons and glia in a microfluidic platform · 2016
  No notice
• Elevated α-synuclein caused by SNCA gene triplication impairs neuronal differentiation and maturation in Parkinson's patient-derived induced pluripotent stem cells · 2015
  No notice
• Clinical application of stem cell therapy in Parkinson's disease · 2012
  No notice
• RNA-Seq of Human Neurons Derived from iPS Cells Reveals Candidate Long Non-Coding RNAs Involved in Neurogenesis and Neuropsychiatric Disorders · 2011
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.